BRPI0906611A2 - Produtos implantáveis compreendendo nanopartículas. - Google Patents

Produtos implantáveis compreendendo nanopartículas.

Info

Publication number
BRPI0906611A2
BRPI0906611A2 BRPI0906611-0A BRPI0906611A BRPI0906611A2 BR PI0906611 A2 BRPI0906611 A2 BR PI0906611A2 BR PI0906611 A BRPI0906611 A BR PI0906611A BR PI0906611 A2 BRPI0906611 A2 BR PI0906611A2
Authority
BR
Brazil
Prior art keywords
nanoparticles
implantable products
implantable
products
Prior art date
Application number
BRPI0906611-0A
Other languages
English (en)
Inventor
Andreas Jordan
Original Assignee
Magforce Nanotechnologies Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Magforce Nanotechnologies Ag filed Critical Magforce Nanotechnologies Ag
Publication of BRPI0906611A2 publication Critical patent/BRPI0906611A2/pt
Publication of BRPI0906611A8 publication Critical patent/BRPI0906611A8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0028—Disruption, e.g. by heat or ultrasounds, sonophysical or sonochemical activation, e.g. thermosensitive or heat-sensitive liposomes, disruption of calculi with a medicinal preparation and ultrasounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0052—Thermotherapy; Hyperthermia; Magnetic induction; Induction heating therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/40—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A61L27/44—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
    • A61L27/446—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix with other specific inorganic fillers other than those covered by A61L27/443 or A61L27/46
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/416—Anti-neoplastic or anti-proliferative or anti-restenosis or anti-angiogenic agents, e.g. paclitaxel, sirolimus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/602—Type of release, e.g. controlled, sustained, slow
    • A61L2300/604—Biodegradation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/80—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special chemical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/56—Porous materials, e.g. foams or sponges

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Materials Engineering (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Composite Materials (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Surgery (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Thermotherapy And Cooling Therapy Devices (AREA)
BRPI0906611A 2008-02-11 2009-02-11 produtos implantáveis compreendendo nanopartículas BRPI0906611A8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102008008522A DE102008008522A1 (de) 2008-02-11 2008-02-11 Implantierbare Nanopartikel-enthaltende Produkte
US7108408P 2008-04-11 2008-04-11
PCT/DE2009/000196 WO2009100716A2 (de) 2008-02-11 2009-02-11 Implantierbare nanopartikel-enthaltende produkte

Publications (2)

Publication Number Publication Date
BRPI0906611A2 true BRPI0906611A2 (pt) 2015-07-14
BRPI0906611A8 BRPI0906611A8 (pt) 2019-01-29

Family

ID=40847365

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0906611A BRPI0906611A8 (pt) 2008-02-11 2009-02-11 produtos implantáveis compreendendo nanopartículas

Country Status (18)

Country Link
US (1) US20110223255A1 (pt)
EP (1) EP2249804B1 (pt)
JP (1) JP5649455B2 (pt)
KR (1) KR101581973B1 (pt)
CN (1) CN101938993A (pt)
AU (1) AU2009214533B2 (pt)
BR (1) BRPI0906611A8 (pt)
CA (1) CA2712832C (pt)
DE (2) DE102008008522A1 (pt)
DK (1) DK2249804T3 (pt)
ES (1) ES2619509T3 (pt)
IL (1) IL207137A (pt)
MX (1) MX2010008806A (pt)
PL (1) PL2249804T3 (pt)
PT (1) PT2249804T (pt)
RU (1) RU2524644C2 (pt)
SG (1) SG188146A1 (pt)
WO (1) WO2009100716A2 (pt)

Families Citing this family (75)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT2347775T (pt) 2005-12-13 2020-07-14 The President And Fellows Of Harvard College Estruturas em andaime para transplante celular
US10328133B2 (en) 2008-02-13 2019-06-25 President And Fellows Of Harvard College Continuous cell programming devices
AU2008361497B2 (en) * 2008-09-04 2014-07-17 Takeshi Kobayashi Methods and kits for hyperthermia and CTLA4 inhibitory therapy
JP5463531B2 (ja) * 2009-07-22 2014-04-09 国立大学法人 東京大学 Ｐｈｄ２発現抑制物質搭載ポリイオンコンプレックス
EP2461828B1 (en) 2009-07-31 2017-06-21 President and Fellows of Harvard College Programming of cells for tolerogenic therapies
ES2600229T3 (es) * 2009-11-12 2017-02-07 Helmholtz-Zentrum Geesthacht Zentrum für Material- und Küstenforschung GmbH Nanopartículas magnéticas biocompatibles para el tratamiento de glioblastomas
DE102009058769A1 (de) 2009-12-16 2011-06-22 MagForce Nanotechnologies AG, 10589 Temperaturabhängige Aktivierung von katalytischen Nukleinsäuren zur kontrollierten Wirkstofffreisetzung
CN102971259A (zh) * 2010-06-29 2013-03-13 皇家飞利浦电子股份有限公司 油酸铁的合成及其用途
US9572880B2 (en) 2010-08-27 2017-02-21 Sienna Biopharmaceuticals, Inc. Ultrasound delivery of nanoparticles
AU2011293132C1 (en) 2010-08-27 2016-04-21 Sebacia, Inc. Compositions and methods for targeted thermomodulation
JP6104806B2 (ja) 2010-10-06 2017-03-29 プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ 材料に基づく細胞治療のための注射可能孔形成性ハイドロゲル
US8944067B2 (en) * 2010-12-15 2015-02-03 Kci Licensing, Inc. Targeted delivery of magnetically tagged active agents in combination with negative pressure wound therapy
US9606277B2 (en) 2011-01-17 2017-03-28 University Of Utah Research Foundation Apparatus and methods for reducing frequency or severity of photophobic responses or modulating circadian cycles
US9764157B2 (en) 2011-01-17 2017-09-19 University Of Utah Research Foundation Methods, systems, and apparatus for reducing the frequency and/or severity of photophobic responses or for modulating circadian cycles
US10359552B2 (en) 2011-01-17 2019-07-23 University Of Utah Research Foundation Methods, systems, and apparatus for reducing the frequency and/or severity of photophobic responses or for modulating circadian cycles
PL2683440T3 (pl) 2011-03-10 2016-05-31 Magforce Ag Wspomagane komputerowo narzędzie symulacyjne do pomocy w planowaniu termoterapii
EP2701745B1 (en) 2011-04-28 2018-07-11 President and Fellows of Harvard College Injectable preformed macroscopic 3-dimensional scaffolds for minimally invasive administration
US9675561B2 (en) 2011-04-28 2017-06-13 President And Fellows Of Harvard College Injectable cryogel vaccine devices and methods of use thereof
US20140093572A1 (en) * 2011-05-06 2014-04-03 Ut-Battelle, Llc Active materials for prevention and treatment of fouled surfaces
WO2012167230A1 (en) 2011-06-03 2012-12-06 President And Fellows Of Harvard College In situ antigen-generating cancer vaccine
CN102379762B (zh) * 2011-08-02 2015-03-25 上海微创医疗器械（集团）有限公司 一种带凹槽的生物可降解支架及其制备方法
EP3038115B1 (en) 2011-08-10 2020-05-06 MagForce AG Method of manufacturing agglomerating magnetic alkoxysilane-coated nanoparticles
BR112014014412A2 (pt) 2011-12-16 2017-06-13 Nanobiotix nanopartículas compreendendo materiais metálicos e de óxido de háfnio, sua preparação e uso
CN104244929B (zh) 2012-04-16 2017-04-05 哈佛学院董事会 用于调节免疫反应的介孔二氧化硅组合物
CA2887687A1 (en) 2012-10-11 2014-04-17 Nanocomposix, Inc. Silver nanoplate compositions and methods
WO2014085651A1 (en) * 2012-11-29 2014-06-05 The Johns Hopkins University A process for making iron oxide nanoparticle preparations for cancer hyperthermia
US20140219926A1 (en) * 2013-02-01 2014-08-07 The Trustees Of Dartmouth College Biodegradable Iron Oxide Nanoparticle Gel for Tumor Bed Therapy
US9849193B2 (en) 2013-02-08 2017-12-26 University Of Louisville Research Foundation, Inc. Nanoparticles for drug delivery
CN103203903A (zh) * 2013-03-25 2013-07-17 海龙核材科技（江苏）有限公司 一种电场磁场下响应的传感材料及其制备方法
JP6564769B2 (ja) * 2013-06-04 2019-08-21 フメディカ アーゲー がん治療において放射線療法と組み合わせて使用するための細胞毒性物質
BR112015031977A2 (pt) * 2013-06-20 2017-07-25 Nanobiotix gel biocompatível, e, kit
EP2823858A1 (en) * 2013-07-12 2015-01-14 Brossel, Rémy System generating a constraint field, and medical device implementing the same
WO2015020936A1 (en) 2013-08-06 2015-02-12 Ut-Battelle, Llc Local thermal actuation of material surfaces via micro- and nanowire heating for the prevention of cellular attachment and biological fouling
WO2015073933A1 (en) * 2013-11-15 2015-05-21 University Of Utah Research Foundation Nanoparticle light filtering method and apparatus
US10234608B2 (en) 2013-11-15 2019-03-19 University Of Utah Research Foundation Nanoparticle light filtering method and apparatus
CN103752849B (zh) * 2014-02-13 2016-02-24 华东理工大学 制备稳定纳米银的方法
US9814631B2 (en) * 2014-03-03 2017-11-14 Sambhu Choudhury Container for surgical absorbent articles
AU2015247450A1 (en) 2014-04-17 2016-10-27 Boston Scientific Scimed, Inc. Devices and methods for therapeutic heat treatment
JP7348708B2 (ja) 2014-04-30 2023-09-21 プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ 組み合わせワクチン装置および癌細胞を殺滅する方法
CN103989552B (zh) * 2014-05-07 2015-10-28 江苏达胜伦比亚生物科技有限公司 一种医用水凝胶凉贴
CZ27466U1 (cs) * 2014-08-21 2014-11-10 Univerzita Tomáše Bati ve Zlíně Biomateriál na bázi hydrogelu citlivý na magnetické podněty
RU2616258C2 (ru) * 2014-11-10 2017-04-13 федеральное государственное автономное образовательное учреждение высшего образования "Московский физико-технический институт (государственный университет)" Способ получения полимерных наночастиц низкосиалированного эритропоэтина с высокой степенью сорбции для лечения неврологических заболеваний
HK1247861A1 (zh) 2015-01-30 2018-10-05 President And Fellows Of Harvard College 用於癌症治疗的肿瘤周围和肿瘤内部材料
WO2016164705A1 (en) 2015-04-10 2016-10-13 Omar Abdel-Rahman Ali Immune cell trapping devices and methods for making and using the same
MA43100A (fr) 2015-05-28 2018-09-05 Nanobiotix Nanoparticules à utiliser en tant que vaccin thérapeutique
EP3344301B1 (en) * 2015-09-04 2020-09-02 University of the Witwatersrand, Johannesburg Biodegradable implant
US10661092B2 (en) 2015-10-07 2020-05-26 Boston Scientific Scimed, Inc. Mixture of lafesih magnetic nanoparticles with different curie temperatures for improved inductive heating efficiency for hyperthermia therapy
RU167739U1 (ru) * 2015-12-02 2017-01-10 Федеральное государственное бюджетное учреждение науки Красноярский научный центр Сибирского отделения Российской академии наук (ФГБУН КНЦ СО РАН) Нанодиски для разрушения опухолевых клеток
EP3411475B1 (en) 2016-02-06 2025-08-27 President and Fellows of Harvard College Recapitulating the hematopoietic niche to reconstitute immunity
CN115404196A (zh) 2016-07-13 2022-11-29 哈佛学院院长等 抗原呈递细胞模拟支架及其制备和使用方法
CN110418651A (zh) 2016-08-02 2019-11-05 哈佛学院院长等 用于调节免疫应答的生物材料
CA3033956A1 (en) * 2016-09-08 2018-03-15 Schaefer Kalk Gmbh & Co. Kg Calcium-salt-containing composite powder having microstructured particles
EP3305334A1 (en) * 2016-10-06 2018-04-11 Universitätsklinikum Jena Magnetic composition and medical material for stimulating vascularisation in internal or external wound of the body
WO2018105779A1 (ko) * 2016-12-07 2018-06-14 서울대학교산학협력단 바이오 패치, 바이오 히터, 바이오 센서, 및 바이오 전자 패치 장치
CZ307237B6 (cs) * 2016-12-16 2018-04-18 Synthesia, A. S. Supramolekulární komplex oxycelulózové matrice s taxolovým derivátem s postupným uvolňováním taxolového derivátu a jeho použití
US20190350867A1 (en) * 2016-12-27 2019-11-21 Soon Kap Hahn Prevention of local tumor recurrence following surgery using sustained and/or delayed release of medicaments contained in micro-particles
US12396951B2 (en) 2016-12-27 2025-08-26 Upexmed Co. Ltd. Prevention of local tumor recurrence following surgery using sustainedand/or delayed release of medicaments contained in micro-particles
DE102017214576A1 (de) * 2017-08-21 2019-02-21 Universität Bielefeld Anorganisch-organischer Nanokomposit mit zellbiologischer und sensorischer Aktivität
RU181004U1 (ru) * 2017-11-14 2018-07-03 Федеральное государственное бюджетное образовательное учреждение высшего образования "Саратовский государственный технический университет имени Гагарина Ю.А." (СГТУ имени Гагарина Ю.А.) Пластинчатый дентальный имплантат для многопозиционного протезирования
RU181003U1 (ru) * 2017-11-14 2018-07-03 Федеральное государственное бюджетное образовательное учреждение высшего образования "Саратовский государственный технический университет имени Гагарина Ю.А." (СГТУ имени Гагарина Ю.А.) Пластинчатый дентальный имплантат для многопозиционного протезирования
RU181002U1 (ru) * 2017-12-25 2018-07-03 Федеральное государственное бюджетное образовательное учреждение высшего образования "Саратовский государственный технический университет имени Гагарина Ю.А." (СГТУ имени Гагарина Ю.А.) Пластинчатый дентальный имплантат для многопозиционного протезирования
KR102200787B1 (ko) * 2017-12-29 2021-01-12 한경대학교 산학협력단 나노셀룰로오스를 이용한 습윤성 탄력붕대
CN108912628A (zh) * 2018-05-31 2018-11-30 苏州乔纳森新材料科技有限公司 一种插管用抗菌纳米材料的制备方法
WO2020061129A1 (en) 2018-09-19 2020-03-26 President And Fellows Of Harvard College Compositions and methods for labeling and modulation of cells in vitro and in vivo
RU189308U1 (ru) * 2019-03-22 2019-05-21 Артем Олегович Бахметьев Трансдермальный пластырь
RU189268U1 (ru) * 2019-03-22 2019-05-17 Артем Олегович Бахметьев Акупунктурная игла
KR102372213B1 (ko) * 2019-09-09 2022-03-08 한국화학연구원 히알루론산 또는 그의 염 및 폴리페놀 화합물을 포함하는 수분해성 필름
WO2021061837A1 (en) 2019-09-23 2021-04-01 President And Fellows Of Harvard College Biomaterial-based antigen free vaccine and the use thereof
WO2021152136A1 (en) 2020-01-31 2021-08-05 Magforce Ag Paste comprising magnetic alkoxysilane-coated metal containing nanoparticles
CN111921003B (zh) * 2020-09-04 2022-06-03 东南大学 一种磁响应热疗可控降解栓塞微球及其制备方法与应用
CN112972778B (zh) * 2021-02-05 2022-05-27 华中科技大学 一种人工膀胱铁磁复合物及其制备方法
CN112972779B (zh) * 2021-02-05 2022-07-12 武汉磁济科技有限公司 一种植入式柔性磁响应人工膀胱基体及其制造方法
CN112933288B (zh) * 2021-02-08 2022-02-22 四川大学 兼具止血和术后抗肿瘤功能的交联止血海绵及其制备方法
US20230061188A1 (en) * 2021-08-30 2023-03-02 Apple Inc. Enhanced mems sensor embedded heater
DE102022115394A1 (de) 2022-06-21 2023-12-21 Rheinisch-Westfälische Technische Hochschule (Rwth) Aachen Implantat und Anordnung aufweisend eine Strahlungsquelle und ein Implantat

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH31064A (en) * 1990-09-07 1998-02-05 Nycomed As Of Nycoveten Polymers containing diester units.
US5411730A (en) 1993-07-20 1995-05-02 Research Corporation Technologies, Inc. Magnetic microparticles
DE4428851C2 (de) 1994-08-04 2000-05-04 Diagnostikforschung Inst Eisen enthaltende Nanopartikel, ihre Herstellung und Anwendung in der Diagnostik und Therapie
US7611533B2 (en) * 1995-06-07 2009-11-03 Cook Incorporated Coated implantable medical device
DE19614136A1 (de) 1996-04-10 1997-10-16 Inst Neue Mat Gemein Gmbh Verfahren zur Herstellung agglomeratfreier nanoskaliger Eisenoxidteilchen mit hydrolysebeständigem Überzug
JPH10328314A (ja) * 1997-06-02 1998-12-15 Nippon Electric Glass Co Ltd 温熱治療用セメント材料及び温熱治療用インプラント材
JPH10337335A (ja) * 1997-06-06 1998-12-22 Nippon Electric Glass Co Ltd 温熱治療用インプラント材
DE19726282A1 (de) 1997-06-20 1998-12-24 Inst Neue Mat Gemein Gmbh Nanoskalige Teilchen mit einem von mindestens zwei Schalen umgebenen eisenoxid-haltigen Kern
US20030073663A1 (en) * 1997-06-25 2003-04-17 David M Wiseman Bioabsorbable medical devices from oxidized polysaccharides
US6267782B1 (en) * 1997-11-20 2001-07-31 St. Jude Medical, Inc. Medical article with adhered antimicrobial metal
DE60044135D1 (de) * 1999-07-16 2010-05-20 Univ Wm Marsh Rice Temperaturabhängiges polymer/nanohüllen-komposite für photothermische modulierte arzneimittelabgabe
DE10059151C2 (de) 2000-11-29 2003-10-16 Christoph Alexiou Magnetische Partikel zur zielgerichteten regionalen Therapie und Verwendung derselben
US6527693B2 (en) * 2001-01-30 2003-03-04 Implant Sciences Corporation Methods and implants for providing radiation to a patient
EP1496860A1 (en) 2001-09-28 2005-01-19 Saoirse Corporation Localized non-invasive biological modulation system
DE10164309A1 (de) * 2001-12-28 2003-07-10 Fraunhofer Ges Forschung Verbesserte strukturiert-funktionale Bindematrices für Biomoleküle
WO2003092791A2 (en) * 2002-05-02 2003-11-13 Scimed Life Systems, Inc. Energetically-controlled delivery of biologically active material from an implanted medical device
US20040136905A1 (en) * 2002-10-15 2004-07-15 Kent Thomas B. Magnetically guided particles for radiative therapies
ITTO20020994A1 (it) * 2002-11-15 2004-05-16 Torino Politecnico Materiali magnetici biocompatibili per il trattamento del cancro mediante ipertermia, e processi per la loro realizzazione.
DE10350248A1 (de) 2003-10-28 2005-06-16 Magnamedics Gmbh Thermosensitive, biokompatible Polymerträger mit veränderbarer physikalischer Struktur für die Therapie, Diagnostik und Analytik
US20070196281A1 (en) 2003-12-31 2007-08-23 Sungho Jin Method and articles for remote magnetically induced treatment of cancer and other diseases, and method for operating such article
EP1718341A2 (en) 2004-01-20 2006-11-08 Alnis Biosciences, Inc. Articles comprising magnetic material and bioactive agents
CN101010004B (zh) * 2004-07-30 2012-10-03 金伯利-克拉克环球有限公司 抗微生物的装置和组合物
US20070243255A1 (en) * 2004-09-28 2007-10-18 Bing Xu Multifunctional supramolecular hydrogels as biomaterials
DE102005016873A1 (de) 2005-04-12 2006-10-19 Magforce Nanotechnologies Ag Nanopartikel-Wirstoff-Konjugate
WO2006125452A1 (en) * 2005-05-23 2006-11-30 Universite De Geneve Injectable superparamagnetic nanoparticles for treatment by hyperthermia and use for forming an hyperthermic implant
FR2889449B1 (fr) 2005-08-05 2011-06-10 Khorionyx Preparations implantables
DE102005039579B4 (de) 2005-08-19 2022-06-30 Magforce Ag Verfahren zur Einschleusung von therapeutischen Substanzen in Zellen
WO2007095454A2 (en) * 2006-02-10 2007-08-23 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Carbon-encased metal nanoparticles and sponges, methods of synthesis, and methods of use
US20080213382A1 (en) * 2007-01-19 2008-09-04 Triton Biosystems, Inc. Thermotherapy susceptors and methods of using same

Also Published As

Publication number Publication date
CA2712832C (en) 2016-05-17
WO2009100716A3 (de) 2010-09-23
RU2010136311A (ru) 2012-03-20
DE102008008522A1 (de) 2009-08-13
MX2010008806A (es) 2010-12-21
DE112009000905A5 (de) 2011-01-20
EP2249804A2 (de) 2010-11-17
BRPI0906611A8 (pt) 2019-01-29
KR20100117602A (ko) 2010-11-03
PL2249804T3 (pl) 2017-07-31
RU2524644C2 (ru) 2014-07-27
SG188146A1 (en) 2013-03-28
JP5649455B2 (ja) 2015-01-07
IL207137A0 (en) 2010-12-30
US20110223255A1 (en) 2011-09-15
EP2249804B1 (de) 2016-12-14
KR101581973B1 (ko) 2015-12-31
WO2009100716A2 (de) 2009-08-20
DK2249804T3 (en) 2017-02-27
CA2712832A1 (en) 2009-08-20
JP2011511684A (ja) 2011-04-14
AU2009214533A1 (en) 2009-08-20
ES2619509T3 (es) 2017-06-26
PT2249804T (pt) 2017-03-20
AU2009214533B2 (en) 2015-01-29
IL207137A (en) 2015-02-26
CN101938993A (zh) 2011-01-05

Similar Documents

Publication Publication Date Title
BRPI0906611A2 (pt) Produtos implantáveis compreendendo nanopartículas.
NO2021006I1 (no) Quofenix, delafloksacin
BRPI0918430A2 (pt) 4-fenil-1h-pirazóis inseticidas.
EP2296593A4 (en) MEDICAL HEAD COVER
BRPI0920428A2 (pt) inalador.
BRPI1014027A2 (pt) suspensão de fármaco de nanopartícula estável.
EP2327448A4 (en) defibrillation catheter
DK2094029T3 (da) Implanterbar transducer
FR2929502B1 (fr) Implant nucleique.
BRPI0908130A2 (pt) Produto
EP2206505A4 (en) Nano-level lactic acid bacterium
UY33125A (es) Diaza-espiro-[5,5]-undecanos
HRP20150107T1 (xx) Derivati dioksabiciklo[3.2.1]oktan-2,3,4-triola
BRPI1016117A8 (pt) derivados de isoxazol-isoxazol e isoxazol-isotiazol.
BRPI0917446A2 (pt) derivados de acilaminobenzamida.
IT1396487B1 (it) Convogliatore.
LT3150178T (lt) Stimuliavimo aparatas
BRPI0913642A2 (pt) produtos de combinação
DK2442870T3 (da) Pyrazinooxazepin-derivater.
HRP20160577T1 (hr) Liječenje osteoartritisa
BRPI0922477A2 (pt) transportador.
IT1392420B1 (it) Lavastoviglie.
IT1396642B1 (it) Statore.
FR2946246B1 (fr) Fauteuil roulant.
FR2928258B1 (fr) Elongateur tendineux implantable

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 4A, 5A E 6A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2344 DE 08-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

B15K Others concerning applications: alteration of classification

Ipc: A61L 15/42 (2006.01), A61K 9/00 (2006.01), A61K 9/